'We're in': Roche and Genen­tech join forces on a multi­bil­lion-dol­lar dis­cov­ery pact with a brash AI up­start

Over the past cou­ple of years, the top ex­ecs at Roche and Genen­tech have inked a flur­ry of deals align­ing the glob­al pair with sev­er­al of the new play­ers that have emerged in the boom­ing AI and ma­chine learn­ing world. That strat­e­gy was su­per­charged in the spring of 2020 by their de­ci­sion to re­cruit Aviv Regev out of the com­pu­ta­tion­al world she oc­cu­pied at the Broad. And to­day they’re tak­ing that com­pu­ta­tion­al ap­proach in R&D to a whole new lev­el.

This article is for premium subscribers only

Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.

UPGRADE